Nongap metabolic acidosis is a common form of both acute and chronic metabolic acidosis. Because derangements in renal acid-base regulation are a common cause of nongap metabolic acidosis, studies to evaluate renal acidification often serve as the mainstay of differential diagnosis. However, in many cases, information obtained from the history and physical examination, evaluation of the electrolyte pattern (to determine if a nongap acidosis alone or a combined nongap and high anion gap metabolic acidosis is present), and examination of the serum potassium concentration (to characterize the disorder as hyperkalemic or hypokalemic in nature) is sufficient to make a presumptive diagnosis without more sophisticated studies. If this information proves insufficient, indirect estimates or direct measurement of urinary NH 4 + concentration, measurement of urine pH, and assessment of urinary HCO 3 2 excretion can help in establishing the diagnosis. This review summarizes current information concerning the pathophysiology of this electrolyte pattern and the value and limitations of all of the diagnostic studies available. It also provides a systematic and cost-effective approach to the differential diagnosis of nongap metabolic acidosis.
Introduction
A non-anion gap pattern is commonly found in patients with both acute and chronic metabolic acidosis. Between 19% (1) and 41% (2) of patients in intensive care units with acute metabolic acidosis and 20%-55% of individuals with chronic uremic acidosis have a nongap pattern (3, 4) . This pattern can originate from a number of pathophysiologic mechanisms; therefore, determination of its cause can be challenging.
In this review, we first describe the mechanisms leading to nongap metabolic acidosis, and then demonstrate that a complete history and physical examination coupled with simple laboratory tests, such as the serum anion gap (and delta gap) and serum potassium concentration, can enable the clinician to determine the cause in a large percentage of cases. When this information is insufficient, studies of renal acidification might be required. The value and limitations of various studies of renal acidification, including urine pH, indirect and direct measures of urine NH 4 + excretion, and renal bicarbonate reabsorption are explored. The resulting systematic approach to the diagnosis of nongap metabolic acidosis should enable the clinician to determine the cause in a costeffective and timely manner.
Recognition and Pathogenesis of the Hyperchloremia and Hypobicarbonatemia of Nongap Acidosis
A nongap metabolic acidosis is characterized by a serum anion gap that is unchanged from baseline, or a decrease in serum [HCO 3 2 ] that exceeds the rise in the anion gap (5, 6) . Whenever possible, the baseline anion gap of the patient should be used rather than the average normal value specific to a particular clinical laboratory (6) and the anion gap should be corrected for the effect of a change in serum albumin concentration (7) . These steps will reduce the chance that a coexisting high anion gap acidosis will be missed if the increase in the serum anion gap does not cause the value to exceed the upper limit of the normal range (8, 9) . Nongap metabolic acidosis (hyperchloremic) refers a metabolic acidosis in which the fall in serum [HCO 3 2 ] is matched by an equivalent increment in serum Cl 2 (6, 10) . The serum anion gap might actually decrease slightly, because the negative charges on albumin are titrated by accumulating protons (6, 11) . Hyperchloremic acidosis is a descriptive term, and does not imply any primary role of chloride in the pathogenesis of the metabolic acidosis.
As shown in Figure 1 , a nongap metabolic acidosis can result from the direct loss of sodium bicarbonate from the gastrointestinal tract or the kidney, addition of hydrochloric acid (HCl) or substances that are metabolized to HCl, impairment of net acid excretion, marked urinary excretion of organic acid anions with replacement with endogenous or administered Cl 2 (12,13), or administration of Cl 2 -rich solutions during resuscitation (14) . The development of hyperchloremic acidosis from administration of HCl is easy to visualize, with titrated HCO 3 2 being replaced by Cl 2 . Similarly, gastrointestinal or urinary NaHCO 3 loss can lead to a deficit of Na + and a reduction in extracellular fluid volume, which stimulates renal retention of Na + and Cl 2 , the lost HCO 3 2 thereby being replaced by the retained Cl 2 .
The nongap metabolic acidosis arising from reduced NH 4 + excretion is thought to result from a limitation in acid excretion (bicarbonate regeneration) in the presence of a relatively unimpeded excretion of filtered anions (e.g., SO 4 22 , H 2 PO 4 2 /HPO 4 22 ) (15) . Serum [HCO 3 ] 2 is first titrated by hydrogen from the acids derived from metabolism resulting in a deficit of HCO 3 2 and surfeit of acid anions. In the absence of sufficient NH 4 + excretion to regenerate the lost HCO 3 2 , the anions are excreted with Na + and K + resulting in a deficit of Na + and avid renal retention of filtered Na + and Cl 2 . Consequently, the retained Cl 2 replaces the lost HCO 3 2 . With disorders such as ketoacidosis or toluene intoxication, metabolic acid production is markedly increased. Although NH 4 + excretion is also strikingly increased, the rate of urinary excretion of the acid anions (ketoanions and hippurate, respectively) exceeds the excretion of NH 4 + . The anions not excreted with NH 4 + are excreted with Na + and K + causing deficits of Na + and inducing avid retention of filtered Na + and Cl 2 , with the lost HCO 3 2 being replaced by the retained Cl 2 .
Sizable expansion of the extracellular fluid during resuscitation with a solution devoid of HCO 3 2 , such as isotonic saline, results in a decrease in serum [HCO 3 2 ] and hyperchloremia without a proportional decrease in PCO 2 (dilution acidosis).
Understanding the various mechanisms producing a nongap metabolic acidosis will aid the clinician in determining the most appropriate information needed to identify the cause of the nongap acidosis.
Systematic Approach to Differential Diagnosis Historical Information and Physical Examination
A complete history and physical examination are very useful in determining the cause. Many cases of acute nongap acidosis are due to infusion of large quantities of Cl 2 -rich solutions during resuscitation; therefore, recognition of this entity could prevent further diagnostic studies (14, 16) .
Cationic amino acids (lysine and arginine hydrochloride) administered in total parenteral solutions are metabolized to HCl (17) . HCO 3 2 loss from the body via the gastrointestinal tract, as with diarrhea, can cause a nongap acidosis. Both the anion composition and the quantity of the diarrheal fluid are determinants of whether metabolic acidosis ensues (18) . Thus, metabolic acidosis is more common with secretory than inflammatory diarrhea, in part because of the higher concentration of HCO 3 2 in the diarrheal fluid of the former type (18) .
Various medications that inhibit renal bicarbonate reabsorption (e.g., acetazolamide), produce hypoaldosteronism (e.g., PG inhibitors), or impair sodium-dependent proton secretion (e.g., amiloride) can contribute to the development of nongap acidosis. Diversion of the urinary collecting system after removal of the bladder either into the sigmoid or the ileum will commonly result in nongap metabolic acidosis (19) .
Genetic disorders that compromise distal or proximal proton secretion can be associated with abnormalities of other organ systems (20) . For example, hearing loss is observed with certain forms of distal renal tubular acidosis (RTA), ocular disease is found with some causes of proximal RTA, and osteopetrosis and mental retardation are seen with mixed proximal-distal RTA. The presence of these abnormalities should cause the clinician to consider accompanying disorders of renal acidification.
Because the kidney is central to the regulation of acidbase balance, evidence of renal insufficiency is important. With metabolic acidosis of CKD, a decrease in serum [HCO 3 2 ] is usually observed once GFR is ,20%-25% of normal (15) . The serum [HCO 3 2 ] is often $15 mEq/L, and there is a rough correlation between the severity of the CKD and the metabolic acidosis (21, 22) . Early in the course of CKD, the metabolic acidosis is often nongap in nature (21) , although a nongap acidosis can be present even with severe CKD (4) .
The presence of hypoaldosteronism or diseases with tubulointerstitial damage, such as sickle cell disease or chronic interstitial nephritis, can reduce renal acid excretion to a Figure 1 . | Potential mechanisms leading to a nongap metabolic acidosis. Several disorders can produce a nongap (hyperchloremic) metabolic acidosis by diverse mechanisms, including loss of bicarbonate in the urine or gastrointestinal tract, failure of bicarbonate generation to match acid production, metabolism of precursors to hydrochloric acid, and administration of chloride-rich solutions. Knowledge of these potential mechanisms can guide the clinician in choosing the studies necessary to obtain the diagnosis while keeping the number of studies to a minimum. GI, gastrointestinal; MA, metabolic acidosis; DRTA, distal RTA; DKA, diabetic ketoacidosis; PRTA, proximal RTA.
greater extent than observed with typical glomerular disease (15, 23, 24) . Therefore, the acidosis might be more severe than expected or appear at an earlier stage of renal dysfunction and will be characterized by a predominant nongap pattern.
It seems reasonable to attribute the acidosis to CKD alone when the acidosis seems to be consistent with the degree of renal impairment. By contrast, it is worthwhile to consider further evaluation of renal acidification if the metabolic acidosis is present early in the course of CKD (eGFR .30 ml/min per 1.73 m 2 ) or is more severe than expected (serum [HCO 3 2 ] ,15 mEq/L), is associated with hyperkalemia out of proportion to the level of renal function, and is largely characterized by a normal anion gap.
Laboratory Studies
Acid-Base Parameters. The electrolyte pattern characteristic of nongap acidosis is indistinguishable from that observed with chronic respiratory alkalosis (10) . Therefore, it is essential to examine the pH and PaCO 2 to be sure that metabolic acidosis, rather than respiratory alkalosis, is present.
Serum Anion Gap and Delta Anion Gap. Individuals with distal and proximal RTA with normal renal function or those given hydrochloric acid precursors have a pure nongap acidosis. By contrast, those with CKD (with or without hyporeninemic hypoaldosteronism), certain organic acidoses such as ketoacidosis, toluene intoxication, and D-lactic acidosis, or profuse diarrhea (sufficient to produce hyperproteinemia and hypotension-induced lactic acidosis) can have a nongap acidosis, a high anion gap acidosis, or both (12, (25) (26) (27) . Therefore, a combined nongap and high anion gap metabolic acidosis would be evidence against distal or proximal RTA with normal renal function, or less than extreme gastrointestinal bicarbonate loss. Thus, determining whether nongap acidosis alone or a combination of the two forms is present can provide useful information. The serum electrolyte patterns of disorders characterized by a nongap acidosis at some point during their course are shown in Table 1 .
Serum Potassium. As shown in Table 2 , the disorders producing a nongap metabolic acidosis can be divided into those associated with a high or normal serum potassium concentration and those in which serum potassium is low. In cases in which serum potassium is elevated, there is often impairment in renal excretion of potassium in addition to the reduction in the renal excretion of acid. Examples include the nongap acidosis of CKD, and that due to hypoaldosteronism or intrinsic damage to the collecting duct. Drugs that inhibit the renin-angiotensin system or block the epithelium-like sodium channel, also impair potassium as well as hydrogen secretion.
With administration of HCl or precursors (28), the serum potassium might be elevated initially because of the pH-dependent efflux of cellular K + . However, kaliuresis occurs as the acidosis persists, causing serum potassium to return to baseline or actually fall below normal (29) . The enhanced kaliuresis has been attributed to increased distal Na + delivery coupled with increased aldosterone secretion (29) (30) (31) .
Disorders in which serum potassium is low include those in which potassium is directly lost from the gastrointestinal tract; however, a gastrointestinal mechanism for hypokalemia is also at play with ureterosigmoidostomy or ureteroileostomy, even though the excreted potassium actually appears in the urine.
Kaliuresis producing hypokalemia is prominent with distal or proximal RTA. The magnitude of the hypokalemia with distal RTA parallels the severity of the acidosis and is related in part to the associated enhanced aldosterone secretion (31) . Correction of the acidosis often attenuates the potassium wasting, although base replacement fails to correct the potassium wasting in some cases, suggesting an intrinsic defect in tubular potassium handling (31) .
With proximal RTA, the hypokalemia is most severe when bicarbonaturia is prominent, as is observed during the generation of the metabolic acidosis or during its treatment with base (31, 32) .
Assessment of Renal Acidification
If the history and physical examination along with simple laboratory studies do not enable the clinician to determine the cause of the metabolic acidosis, assessment of renal acidification is indicated (25, 26, 33) .
Assessment of Net Acid Excretion. An increase in the body's acid load causes a rise in net acid excretion (primarily in the form of urinary NH 4 + appropriate quantities of urinary NH 4 + can produce a nongap metabolic acidosis. Therefore, assessment of urinary NH 4 + excretion can be a valuable step in the evaluation of patients with a nongap metabolic acidosis (34, 35) .
As indicated in Table 3 , individuals in whom the acidosis is due only to a defect in distal acidification will have urine NH 4 + excretion ,20-40 mEq/d. On the other hand, the excretion of ,200 mEq/d of NH 4 + at 3-5 days after an acidifying stimulus will reflect at least a partial defect in renal acidification.
Indirect Estimates of Urinary NH 4
+ Excretion Because direct measurements of urinary NH 4 + excretion are not available in most clinical laboratories, investigators have made use of the effect of changes in urinary NH 4 + and its accompanying anions on urinary charge (urine anion gap) or osmolality (urine osmolal gap) to indirectly estimate urinary NH 4 + concentration (25, (36) (37) (38) (39) .
Urine Anion Gap. The total charge of the positive ionic species appearing in the urine, including Na + + K + + Ca 2+ + Mg 2+ + NH 4 + , is equal to the total charge of the negative ionic species in the urine, including Cl 2 + organic anions (OA 2 ) + HCO 3 2 + SO 4 22 + H 2 PO 4 -/HPO 4 22 . Under most circumstances, any increment in urine NH 4 + is accompanied by an increment in urine Cl 2 . Assuming that the urinary concentrations of the cations and anions other than Na + , K + , and Cl 2 and NH 4 + do not change appreciably with an acid load (an assumption that is not completely correct), the urinary NH 4 + concentration can be estimated by subtracting the Cl 2 concentration from the sum of the concentrations of Na + + K + (36, 37) , using a calculation termed the urine anion gap, which is as follows:
In studies examining the relationship between urine NH 4 + concentration and the urine anion gap, a linear relationship was detected (37) , with the urine anion gap becoming more negative as urinary NH 4 + excretion rose. The following mathematical formula was derived from these studies: NH 4 + = 20.8 (urine anion gap) + 82, which allowed for an estimate of urinary NH 4 + excretion (37) . In general, the urine anion gap averaged 220 to 250 mEq/L in individuals who retained the ability to excrete adequate quantities of NH 4 + (36, 37) . By contrast, it was less negative or even positive in individuals in whom urinary NH 4 + excretion was low (36) .
There are limitations to the use of the urine anion gap. When anions other than Cl 2 , such as b-hydroxybutyrate or acetoacetate in ketoacidosis or hippurate in toluene intoxication, are excreted in the company of NH 4 + (13, 25, 26) , the value for NH 4 + derived using the urine anion gap will significantly underestimate the actual urinary NH 4 + excretion (25). An additional situation in which the urinary anion gap (or other measures of renal acidification) might not reflect a Maximal renal NH 4 + excretion will be reached by 3-5 days and could be less than this if values are obtained after ,3-5 days. b Any value less than maximal value obtained after 3-5 days will reflect a defect in net acid excretion. Although controversial, some studies indicate that urine net acid excretion can be below the level expected for the acidemic state in patients with proximal RTA both during its genesis (when bicarbonate in the urine is ample) and during the steady state (when bicarbonate is absent from the urine).
the intrinsic ability of the kidney to excrete net acid is when distal Na + delivery (and subsequent Na + reabsorption) is impaired (as is observed with a Na + -avid state detected by urine Na + ,25 mEq/L) (40) . The reduced distal Na + reabsorption decreases the lumen negative electrical gradient that favors hydrogen secretion and thus causes a functional distal RTA characterized by reduced NH 4 + excretion and an elevated urine pH. This state can be reversed by augmenting distal Na + delivery either by volume expansion or other methods of increasing distal Na + delivery such as administration of sodium sulfate.
Urine Osmolal Gap. To overcome some of the limitations of the urine anion gap, the urine osmolal gap was developed (25, 41, 42) . The osmolality of the urine is the result of the presence of the charged cations and their accompanying anions, as well as that of the neutral substances, including creatinine, urea, and glucose. The NH 4 + concentration therefore can be estimated by subtracting the contributions to the osmolality of all of these substances except NH 4 + from the measured osmolality, a calculation termed the urine osmolal gap (25, 41) . Because it was assumed that the concentrations of Mg 2+ , Ca 2+ , H 2 PO 4 2 /HPO 4 -, and creatinine would not change appreciably with an acid load, these values were omitted from the formula. Furthermore, to simplify the calculation, the contribution of the anions accompanying Na + and K + were accounted for by multiplying the concentrations of the cations by 2: 2
This method of estimating urinary NH 4 + concentration enabled the clinician to assess changes in NH 4 + concentration irrespective of the accompanying anion (13, 25, 26) . It is therefore useful in the evaluation of all causes of nongap metabolic acidosis (25, 26, 38, 43) .
Studies examining the relationship between urine NH 4 + concentration estimated from the urine osmolal gap and the actual urine NH 4 + concentration in individuals with and without metabolic acidosis revealed a strong positive linear correlation, the urine osmolal gap increasing as urine NH 4 + excretion rose (38, 41) . A simple modification of this formula, in which the value obtained was divided by 2 to reflect the contribution of the anions accompanying NH 4 + to the osmolality, termed the modified urine osmolal gap, resulted in values close to the measured urine NH 4 + (38,39,41):
The value for NH 4 + obtained can also be expressed per gram of creatinine or per millimole of creatinine excreted to obtain an estimate of daily excretion. When expressed in the latter fashion, a normal ratio is .3. Although this method represented an improvement over the urine anion gap, potential inaccuracies were recognized if there was enhanced excretion of unusual uncharged compounds (such as alcohols), polyvalent anions, or cations (such as Ca 2+ and Mg 2+ ).
The modified urine osmolal gap is not capable of detecting small changes in urine NH 4 + excretion. Indeed, comparison of values of urine NH 4 + estimated using this formula with values measured directly in healthy controls without an exogenous acid load (39) revealed that estimated values could be as much as 43.2 mmol/L below or 34.4 mmol/L above those measured directly.
Therefore, as concluded when the concept was first proposed, this method is most valuable at the bedside to screen for gross changes in urine NH 4 + concentration to differentiate between patients with appropriate increments in urine NH 4 + concentration and those in whom urine NH 4 + excretion is compromised (25, 44) . Direct Measurement of Urinary NH 4 + . To date, NH 4 + has not routinely been measured directly because the traditional methods utilized for this purpose, such as the formaldehyde titration method, are labor intensive and expensive (45) . However, the enzymatic assay used in many clinical laboratories for measuring serum NH 4 + can be easily modified by predilution of the urine by 1:100 or greater, thereby enabling this determination to be accomplished using an autoanalyzer (45, 46) . Studies comparing the accuracy of this method with the formaldehyde titration method show good agreement (45, 46) , and reveal that the determination can be completed within 30 minutes. The estimated cost of each determination is approximately $5-6 USD (46). Further study of the usefulness and cost-effectiveness of this method seems warranted. Urine pH. Normal individuals subject to acute acid loading have a urine pH ,5.5 and often ,5.3, whereas individuals with impaired acidification, such as those with hypokalemic distal RTA (type 1), have a urine pH .5.5 (47, 48) . Although urine pH is reduced to ,5.5 in normal individuals in response to an acute acid load (minutes to hours), with more prolonged metabolic acidosis (more than a few days) urine pH can increase to .5.5, even in the presence of ample quantities of NH 4 + (36, 49) . This rise in urine pH has been attributed to buffering of H + by the increased NH 3 produced by the kidney. Thus, a urine pH .5.5 will not necessarily be associated with a low NH 4 + excretion. Even if urine pH is appropriately low (i.e., ,5.5), urine NH 4 + excretion can be compromised as observed, for example, with hypoaldosteronism (type IV RTA) (36) . The low NH 4 + excretion in this disorder has been attributed in part to suppression of ammonia synthesis by hyperkalemia because lowering serum potassium concentration can reverse the defect (50) .
Although urine pH considered in isolation is not adequate to assess renal acidification, once urinary NH 4 + excretion has been established as low, measurement of urine pH can be helpful in distinguishing among disorders in which the ability to generate a maximal hydrogen gradient is compromised (type I distal RTA, hyperkalemic distal RTA characterized by tubular damage) and those in which it is unaltered (such as hypoaldosteronism). In all instances, urine should be collected under mineral oil to prevent dissipation of CO 2 and a falsely elevated urine pH. Figure 2 shows typical urine pHs with various disorders causing nongap acidosis.
Other Measures of Distal Urinary Acidification
Studies to further elucidate the nature of the renal acidification defect have been developed and could be of interest (51) . Two of the most frequently utilized measures are described below.
Urine-Blood PCO 2 Test. NaHCO 3 is infused intravenously at a rate to maintain serum [HCO 3 2 ] at 25-26 mEq/L and urine pH at approximately 7.5, and the urine-blood pCO 2 difference is calculated (52) . A value $30 mmHg (often close to 70 mmHg) is found in normal individuals and a value ,30 mmHg is found in those with impaired distal hydrogen secretion. Using these criteria, the test was shown to have a high specificity and sensitivity for detecting defects in distal proton secretion (52) . However, cases have been reported in which the urine-blood PCO 2 is low, but NH 4 + excretion is appropriately increased (35) . Therefore the test should be done only after NH 4 + excretion has been determined.
Furosemide Administration. Administration of furosemide shifts sodium distally augmenting distal hydrogen secretion. Prior salt depletion or co-administration of mineralocorticoid during the test was shown to increase the sensitivity of the test. Practically, after a baseline urine sample, 40-80 mg of furosemide and 1 mg of fludrocortisone are given; samples of urine are collected for 3-4 hours and urine pH is evaluated. Normal individuals lower urine pH ,5.3, whereas those with defective hydrogen secretion fail to lower urine pH ,6.0 (51).
Additional Studies
Additional studies might be helpful in differential diagnosis of disorders with impaired net acid excretion. Measurements of plasma aldosterone and renin will confirm the diagnosis of aldosterone deficiency, with or without hyporeninemia. Measurement of urinary citrate can be helpful in distinguishing between individuals with distal forms of RTA and those with proximal RTA. It will be low in the former and often elevated in the latter disorder.
Renal Bicarbonate Reabsorption
In disorders in which the function of the proximal tubule is compromised (proximal RTA), there is a decrease in the renal HCO 3 2 threshold, normally 22 mEq/L in infants and 25-26 mEq/L in children and adults (53) . The threshold can be variable in individuals with proximal RTA but usually is .15 mEq/L. Bicarbonate appears in the urine when serum [HCO 3 2 ] is above the threshold, whereas bicarbonate disappears from the urine when it is below this value. In the latter stage, the urine pH will be ,5.5 although urine NH 4 + excretion has been found to be low (54) . Therefore, this disorder can have some characteristics of low aldosterone states. However, proximal RTA will be easily recognized by the requirements for large quantities of base to raise serum [HCO 3 2 ], the appearance of bicarbonaturia at a normal serum [HCO 3 2 ] concentration, and the presence of hypokalemia.
Proximal RTA can be confirmed by demonstrating that fractional HCO 3 2 excretion is .15%-20% when serum [HCO 3 2 ] is raised to normal values by infusion of NaHCO 3 :
Although bicarbonate reabsorption can be affected alone, defects are more commonly present in the function of other proximal tubule transporters such as sodium-dependent glucose and phosphate transporters and amino acid and uric acid transporters. If so, glucose, phosphate, uric acid, and amino acids will appear in the urine in increased amounts often leading to a reduction in their serum concentrations. Therefore, in patients suspected of having Similarly, urine pH will be ,5.5 in patients with CKD, those with low aldosterone states, and PRTA when the serum [HCO 3 2 ] is below the reabsorptive threshold. By contrast, it will be .5.5 in patients with DRTA, those with tubular resistance to aldosterone, and those with PRTA when the serum [HCO 3 2 ] is above the reabsorptive threshold. THD, reabsorptive threshold; C, controls; DRTA, distal RTA; aldo, aldosterone;
tub. res, tubular resistance; PRTA, proximal RTA.
proximal RTA, measurement of serum glucose, uric acid, and phosphate is indicated. Table 4 summarizes the studies commonly utilized in the evaluation of nongap metabolic acidosis.
A nongap metabolic acidosis is increasingly recognized in patients with acute or chronic metabolic acidosis. Defects in renal regulation of acid-base balance can cause this electrolyte pattern. This pattern is also present in individuals Obtain a good history and physical examination to determine if acidosis is acute or chronic in nature and to look for evidence of disorders associated with nongap acidosis Examine the patient's baseline anion gap corrected for serum albumin to determine if nongap acidosis or combined nongap and high anion gap acidosis is present Examine serum potassium concentration to determine if it is elevated/normal or low Examine eGFR to determine if renal insufficiency is present, which could be associated with nongap acidosis If this information is insufficient to make a diagnosis, obtain measures of renal acidification Measure urine osmolality Na + , K + , urea nitrogen, and glucose, if glycosuria present, to calculate urine osmolal gap If urine NH 4 + assay is readily available, determine urine NH 4 + Once urine NH 4 + is determined to be low, measure urine pH If proximal RTA is suspected, evaluate renal bicarbonate reabsorption If proximal RTA is suspected, evaluate urine for glucosuria, aminoaciduria, and phosphaturia. Check serum for levels of these substances
